Diabetic foot infection: A multidisciplinary approach;Traitement du pied diabétique infecté: Une approche multidisciplinaire par excellence

Revue Medicale Suisse

Volumn 7, Issue 292, 2011, Pages 894-897

  Darbellay, Pauline ^a   Uçkay, Ilker ^a   Dominguez, Dennis ^a   Mugnai, Damiano ^a   Filtri, Lucia ^a   Lew, Daniel ^a   Assal, Mathieu ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DIABETIC FOOT; DIABETIC FOOT INFECTION; FOOT AMPUTATION; MEDICAL SPECIALIST; REVIEW;

AMPUTATION; ANTI-BACTERIAL AGENTS; DEBRIDEMENT; DIABETIC FOOT; HUMANS; OSTEOMYELITIS; PATIENT CARE TEAM;

EID: 79956021772     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Felix B. Der diabetische Fuss. Schweiz Med Forum 2001;17:431-6.
2. Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999;22:382-7. (Pubitemid 29106890)
3. Lipsky BA, Berendt AR, Deery HG, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004;39:885-910.
4. Berendt AR, Peters EJ, Bakker K, et al. Diabetic foot osteomyelitis: A progress report on diagnosis and a systematic review of treatment. Diabetes Metab Res Rev 2008;24:145-61.
5. Schaper NC, Huijberts M, Pickwell K. Neurovascular control and neurogenic inflammation in diabetes. Diabetes Metab Res Rev 2008;24:40-4.
6. Chantelau E, Richter A, Ghassem-Zadeh N, Poll LW. «Silent» bone stress injuries in the feet of diabetic patients with polyneuropathy: A report on 12 cases. Arch Orthop Trauma Surg 2007;127:171-7.
7. Gallacher SJ, Thomson G, Fraser WD, et al. Neutrophil bactericidal function in diabetes mellitus: Evidence for association with blood glucose control. Diabet Med 1995;12:916-20.
8. Frykberg RG, Zgonis T, Armstrong DG, et al. Diabetic foot disorders : A clinical practice guideline. J Foot Ankle Surg 2006;45:1-66.
9. Rogers LC, Andros G, Caporusso J, et al. Toe and flow: Essential components and structure of the amputation prevention team. J Vasc Surg 2010;52:23-7.
10. Petrova NL, Edmonds ME. Charcot neuro-osteoarthropathy-current standards. Diabetes Metab Res Rev 2008;24:58-61.
11. Davis WA, Norman PE, Bruce DG, et al. Predictors, consequences and costs of diabetes-related lower extremity amputation complicating type 2 diabetes: The Fremantle diabetes study. Diabetologia 2006;49: 2634-41.
12. Carter SA, Tate RB. The relationship of the transcutaneous oxygen tension, pulse waves and systolic pressures to the risk for limb amputation in patients with peripheral arterial disease and skin ulcers or gangrene. Int Angiol 2006;25:67-72.
13. Ledoux WR, Shofer JB, Smith DG, et al. Relationship between foot type, foot deformity, and ulcer occurrence in the high-risk diabetic foot. J Rehabil Res Dev 2005;42:665-71
14. Butalia S, Palda VA, Sargeant RJ, Detsky AS, Mourad O. Does this patient with diabetes have osteomyelitis of the lower extremity? JAMA 2008;299:806-13.
15. Schols JM, Heyman H, Meijer EP. Nutritional support in the treatment and prevention of pressure ulcers: An overview of studies with arginine enriched oral nutritional supplement. J Tissue Viability 2009;18: 72-9.